Neurotrophic Factors in ALS: A Winning Combination?
Researchers first turned to neurotrophic factors (NTFs) as a potential treatment strategy for ALS in the early 1990s in hopes to shield motor neurons from destruction. But the clinical translation of these approaches has proved challenging. Now, a new study suggests that multiple factors may be needed to provide the most therapeutic benefit. The study, led by Georg Haase at the Aix-Marseille University in France, found that NTFs promote the survival of distinct classes of motor neurons in the lumbar spinal cord. The findings suggest that a combination of these neuroprotective substances may be needed to protect motor neurons affected by the disease. The study appeared on March 16 in the Proceedings of the National Academy of Sciences.
For More Information: ALS RESEARCH FORUM: NTF
Click here for a list of clinical trials worldwide for ALS patients: ALS-TDI
NEALS (Northeast ALS Consortium) Webinars
NEALS offers a variety of live and archived webinars on a variety of topics relating to ALS. Live webinars offer the opportunity to ask questions directly to the experts running the seminar. For a list of upcoming and archived webinars: NEALS
2016's Biggest Advances in ALS
In 2016, a significant number of ALS research discoveries, advances in clinical trials, collaborations and strategic initiatives all accelerated the pace of discovery in finding treatments and a cure for ALS.
The ALS Association has pulled together what they think are 10 of 2016’s biggest advances in ALS research.
To read: 2016 Advances
Weather and MDA
If you are impacted by severe weather and need MDA services -- including help repairing or replacing durable medical equipment that's been damaged by a storm or information about local groups offering emergency assistance and/or shelter, contact MDA by calling (800) 572-1717 or emailing email@example.com.